Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Long-QT syndromes are heritable diseases associated with prolongation of the QT interval on an electrocardiogram and a high risk of sudden cardiac death due to ventricular tachyarrhythmia. In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier I(Ks) current. METHODS: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene. We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells. With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes. RESULTS: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes. Individual cells showed a “ventricular,” “atrial,” or “nodal” phenotype, as evidenced by the expression of cell-type–specific markers and as seen in recordings of the action potentials in single cells. The duration of the action potential was markedly prolonged in “ventricular” and “atrial” cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects. Further characterization of the role of the R190Q–KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant negative trafficking defect associated with a 70 to 80% reduction in I(Ks) current and altered channel activation and deactivation properties. Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype. CONCLUSIONS: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes. The patient-derived cells recapitulated the electrophysiological features of the disorder. (Funded by the European Research Council and others.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ventricle beat rates showed a positive chronotropic response over the concentration range in both the NRVM and hiPSC-CM ventricles (Fig. 3c), as expected for healthy NRVM59, hiPSC-CM60, engineered hiPSC-CM cardiac tissues16, and human patients61.”
From A tissue-engineered scale model of the heart ventricle (2018) · cites this paper as [60]
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Previous studies using iPSC-derived cardiomyocytes from type-1 LQTS patients revealed that the mutation in KCNQ1 caused potassium ion channel dysfunction resulting in sarcolemmal deficiency [5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Tumorous cell lines, although able to proliferate, are often incorporated with unwanted genetic or chromosomal abnormalities, which might induce interference to the resulting outcomes [4,5].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Models built with iPSC derivatives also demonstrate functional and phenotypic traits comparable to their human in vivo parallel [4,5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,459
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming
Jaenisch, R., & Young, R. (2008) · Cell · doi:10.1016/j.cell.2008.01.015 · Cited by 1,427
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Research works printed but not linked: 2
- Freund C, 2010, Neth Heart J, 18, 51
- Brunner M, 2008, J Clin Invest, 118, 2246
Cited by
Items 101–200 of 1,000
Protze, S. I., Lee, J. H., & Keller, G. M. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.07.010 · Cited by 162
Tzatzalos, E., Abilez, O. J., Shukla, P., & Wu, J. C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.010 · Cited by 162
“For example, some of thefirst iPSC-derived cellularmodelswere developed for LEOPARD syndrome [21], long QT [22,23], familial dilated cardiomyopathy (DCM) [24], familial hypertrophic cardiomyopathy (HCM) [25], Timothy syndrome [26], and aldehyde dehydrogenase 2 genetic polymorphism [27].”
Gherghiceanu, M., Barad, L., Novak, A., Reiter, I., Itskovitz-Eldor, J., Binah, O., & Popescu, L. M. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01417.x · Cited by 155
Present state and future perspectives of using pluripotent stem cells in toxicology research
Wobus, A. M., & Löser, P. (2011) · Archives of Toxicology · doi:10.1007/s00204-010-0641-6 · Cited by 159
Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human Atrium
Lemme, M., Ulmer, B. M., Lemoine, M. D., Zech, A. T. L., Flenner, F., Ravens, U., Reichenspurner, H., Rol-Garcia, M., Smith, G., Hansen, A., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.10.008 · Cited by 158
Krahn, A. D., Laksman, Z., Sy, R. W., Postema, P. G., Ackerman, M. J., Wilde, A. A. M., & Han, H. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.02.017 · Cited by 193
Abilez, O. J., Tzatzalos, E., Yang, H., Zhao, M.-T., Jung, G., Zöllner, A. M., Tiburcy, M., Riegler, J., Matsa, E., Shukla, P., et al. (2018) · Stem Cells · doi:10.1002/stem.2732 · Cited by 153
Long QT Syndrome: Genetics and Future Perspective
Wallace, E. J., Howard, L., Liu, M., O’Brien, T., Ward, D., Shen, S., & Prendiville, T. W. (2019) · Pediatric Cardiology · doi:10.1007/s00246-019-02151-x · Cited by 168
Smith, A. S. T., Macadangdang, J. R., Leung, W. W., Laflamme, M. A., & Kim, D. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.002 · Cited by 169
Ren, Y., Lee, M. Y., Schliffke, S., Paavola, J., Amos, P. J., Ge, X., Ye, M., Zhu, S., Senyei, G., Lum, L., et al. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.04.012 · Cited by 148
Biomaterial based cardiac tissue engineering and its applications
Huyer, L. D., Montgomery, M., Zhao, Y., Xiao, Y., Conant, G., Korolj, A., & Radisic, M. (2015) · Biomedical Materials · doi:10.1088/1748-6041/10/3/034004 · Cited by 145
Beers, M. F., & Moodley, Y. P. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0426ps · Cited by 165
Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle
Xiao, Y., Zhang, B., Liu, H., Miklas, J. W., Gagliardi, M., Pahnke, A., Thavandiran, N., Sun, Y., Simmons, C., Keller, G., et al. (2014) · Lab Chip · doi:10.1039/c3lc51123e · Cited by 144
Genome editing of human pluripotent stem cells to generate human cellular disease models
Musunuru, K. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012054 · Cited by 147
Hartman, M. E., Dai, D.-F., & Laflamme, M. A. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.004 · Cited by 138
Opportunities for Use of Human iPS Cells in Predictive Toxicology
Anson, B. D., Kolaja, K. L., & Kamp, T. J. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.9 · Cited by 145
Drug screening for human genetic diseases using iPSC models
Elitt, M. S., Barbar, L., & Tesar, P. J. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy186 · Cited by 140
Overcoming reprogramming resistance of Fanconi anemia cells
Müller, L. U. W., Milsom, M. D., Harris, C. E., Vyas, R., Brumme, K. M., Parmar, K., Moreau, L. A., Schambach, A., Park, I.-H., London, W. B., et al. (2012) · Blood · doi:10.1182/blood-2012-02-408674 · Cited by 141
Antisense‐mediated exon skipping: a therapeutic strategy for titin‐based dilated cardiomyopathy
Gramlich, M., Pane, L. S., Zhou, Q., Chen, Z., Murgia, M., Schötterl, S., Goedel, A., Metzger, K., Brade, T., Parrotta, E. I., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505047 · Cited by 150
Self-citationSiu, C.-W., Lee, Y.-K., Ho, J. C.-Y., Lai, W.-H., Chan, Y.-C., Ng, K.-M., Wong, L.-Y., Au, K.-W., Lau, Y.-M., Zhang, J., et al. (2012) · Aging · doi:10.18632/aging.100503 · Cited by 141
Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons
Jiao, J., Yang, Y., Shi, Y., Chen, J., Gao, R., Fan, Y., Yao, H., Liao, W., Sun, X.-F., & Gao, S. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt275 · Cited by 143
Human Engineered Heart Tissue Patches Remuscularize the Injured Heart in a Dose-Dependent Manner
Querdel, E., Reinsch, M. C., Castro, L., Köse, D., Bähr, A., Reich, S., Geertz, B., Ulmer, B. M., Schulze, M. L., Lemoine, M. D., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.047904 · Cited by 150
Paci, M., Hyttinen, J., Aalto‐Setälä, K., & Severi, S. (2013) · Annals of Biomedical Engineering · doi:10.1007/s10439-013-0833-3 · Cited by 150
Huang, H.-P., Chen, P.-H., Hwu, W.-L., Chuang, C.-Y., Chien, Y.-H., Stone, L., Chien, C.-L., Li, L.-T., Chiang, S.-C., Chen, H.-F., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr424 · Cited by 138
Comparison of Human Induced Pluripotent and Embryonic Stem Cells: Fraternal or Identical Twins?
Narsinh, K. H., Plews, J., & Wu, J. C. (2011) · Molecular Therapy · doi:10.1038/mt.2011.41 · Cited by 135
Capacitation of human naïve pluripotent stem cells for multi-lineage differentiation
Rostovskaya, M., Stirparo, G. G., & Smith, A. G. (2019) · Development · doi:10.1242/dev.172916 · Cited by 145
Cardiac Differentiation of Pluripotent Stem Cells
Rajala, K., Pekkanen-Mattila, M., & Aalto‐Setälä, K. (2011) · Stem Cells International · doi:10.4061/2011/383709 · Cited by 157
Jonsson, M. K. B., Vos, M. A., Mirams, G. R., Duker, G., Sartipy, P., de Boer, T. P., & van Veen, T. A. B. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.02.002 · Cited by 137
FutureTox II: In vitro Data and In Silico Models for Predictive Toxicology
Knudsen, T. B., Keller, D. A., Sander, M., Carney, E. W., Doerrer, N. G., Eaton, D. L., Fitzpatrick, S. C., Hastings, K. L., Mendrick, D. L., Tice, R. R., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfu234 · Cited by 132
Kernik, D. C., Morotti, S., Wu, H., Garg, P., Duff, H. J., Kurokawa, J., Jalife, J., Wu, J. C., Grandi, E., & Clancy, C. E. (2019) · The Journal of Physiology · doi:10.1113/jp277724 · Cited by 141
Di Pasquale, E., Lodola, F., Miragoli, M., Denegri, M., Avelino-Cruz, J. E., Buonocore, M., Nakahama, H., Portararo, P., Bloise, R., Napolitano, C., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.369 · Cited by 129
Shinnawi, R., Huber, I., Maizels, L., Shaheen, N., Gepstein, A., Arbel, G., Tijsen, A. J., & Gepstein, L. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.08.009 · Cited by 137
Mehta, A., Ramachandra, C. J. A., Singh, P., Chitre, A., Lua, C. H., Mura, M., Crotti, L., Wong, P., Schwartz, P. J., Gnecchi, M., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx394 · Cited by 133
Malan, D., Friedrichs, S., Fleischmann, B. K., & Sasse, P. (2011) · Circulation Research · doi:10.1161/circresaha.111.243139 · Cited by 129
Sabapathy, V., & Kumar, S. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12839 · Cited by 123
Induced pluripotent stem cells: developmental biology to regenerative medicine
Nelson, T. J., Martinez‐Fernandez, A., & Terzic, A. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.159 · Cited by 135
Induced Pluripotent Stem Cells and Their Potential for Basic and Clinical Sciences
Ye, L., Swingen, C., & Zhang, J. J. (2013) · Current Cardiology Reviews · doi:10.2174/157340313805076278 · Cited by 168
Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery
Mercola, M., Colas, A., & Willems, E. (2013) · Circulation Research · doi:10.1161/circresaha.111.250266 · Cited by 122
The Broad Spectrum of LMNA Cardiac Diseases: From Molecular Mechanisms to Clinical Phenotype
Crasto, S., My, I., & Pasquale, E. D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00761 · Cited by 138
Davis, R. P., van den Berg, C. W., Casini, S., Braam, S. R., & Mummery, C. L. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.001 · Cited by 134
Modeling Supravalvular Aortic Stenosis Syndrome With Human Induced Pluripotent Stem Cells
Ge, X., Ren, Y., Bartulos, O., Lee, M. Y., Yue, Z., Kim, K.-Y., Li, W., Amos, P. J., Bozkulak, E. C., Iyer, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.116996 · Cited by 122
Induced Pluripotent Stem Cell–Derived Cardiomyocytes: Boutique Science or Valuable Arrhythmia Model?
Knollmann, B. C. (2013) · Circulation Research · doi:10.1161/circresaha.112.300567 · Cited by 118
Functional Myogenic Engraftment from Mouse iPS Cells
Darabi, R., Pan, W., Bosnakovski, D., Baik, J., Kyba, M., & Perlingeiro, R. C. R. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9258-2 · Cited by 116
Farra, N., Zhang, W.-B., Pasceri, P., Eubanks, J. H., Salter, M. W., & Ellis, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.180 · Cited by 118
Modeling Short QT Syndrome Using Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes
El‐Battrawy, I., Lan, H., Cyganek, L., Zhao, Z., Li, X., Buljubasic, F., Lang, S., Yücel, G., Sattler, K., Zimmermann, W., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007394 · Cited by 124
Garg, P., Garg, V., Shrestha, R., Sanguinetti, M. C., Kamp, T. J., & Wu, J. C. (2018) · Circulation Research · doi:10.1161/circresaha.118.311209 · Cited by 129
Bett, G. C. L., Kaplan, A. D., Lis, A., Cimato, T. R., Tzanakakis, E. S., Zhou, Q., Morales, M. J., & Rasmusson, R. L. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.09.061 · Cited by 123
Salvarani, N., Crasto, S., Miragoli, M., Bertero, A., Paulis, M., Kunderfranco, P., Serio, S., Forni, A., Lucarelli, C., Ferro, M. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09929-w · Cited by 127
Šarić, A., Andréau, K., Armand, A., Møller, I. M., & Petit, P. X. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2015.00359 · Cited by 126
Biology of the cardiac myocyte in heart disease
Peter, A. K., Bjerke, M. A., & Leinwand, L. A. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-01-0038 · Cited by 128
Three-dimensional filamentous human diseased cardiac tissue model
Ma, Z., Koo, S., Finnegan, M. A., Loskill, P., Huebsch, N., Marks, N. C., Conklin, B. R., Grigoropoulos, C. P., & Healy, K. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.052 · Cited by 113
Zhang, X.-H., Haviland, S., Wei, H., Šarić, T., Fatima, A., Hescheler, J., Cleemann, L., & Morad, M. (2013) · Cell Calcium · doi:10.1016/j.ceca.2013.04.004 · Cited by 108
Materials Science and Tissue Engineering: Repairing the Heart
Radisic, M., & Christman, K. L. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.05.003 · Cited by 132
Campostrini, G., Meraviglia, V., Giacomelli, E., van Helden, R. W. J., Yiangou, L., Davis, R. P., Bellin, M., Orlova, V. V., & Mummery, C. L. (2021) · Nature Protocols · doi:10.1038/s41596-021-00497-2 · Cited by 109
Self-citationLiras, A. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-131 · Cited by 131
Physiologically inspired cardiac scaffolds for tailored in vivo function and heart regeneration
Kaiser, N. J., & Coulombe, K. L. K. (2015) · Biomedical Materials · doi:10.1088/1748-6041/10/3/034003 · Cited by 107
Jang, J., Yoo, J.-E., Lee, J., Lee, D. R., Kim, J. Y., Huh, Y. J., Kim, D., Park, C., Hwang, D., Kim, H.-S., et al. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.3.015 · Cited by 120
The application of convolutional neural network to stem cell biology
Kusumoto, D., & Yuasa, S. (2019) · Inflammation and Regeneration · doi:10.1186/s41232-019-0103-3 · Cited by 118
Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes
Mehta, A., Sequiera, G. L., Ramachandra, C. J. A., Sudibyo, Y., Chung, Y., Sheng, J., Wong, K. Y., Tan, T. H., Wong, P., Liew, R., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu060 · Cited by 110
Du, D. T. M., Hellen, N., Kane, C., & Terracciano, C. M. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2014.11.008 · Cited by 109
Takeda, M., Miyagawa, S., Fukushima, S., Saito, A., Ito, E., Harada, A., Matsuura, R., Iseoka, H., Sougawa, N., Mochizuki‐Oda, N., et al. (2017) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2017.0247 · Cited by 110
Fiedler, L. R., Chapman, K., Xie, M., Maifoshie, E., Jenkins, M., Golforoush, P. A., Bellahcene, M., Noseda, M., Faust, D., Jarvis, A., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.01.013 · Cited by 102
Ojala, M., Prajapati, C., Pölönen, R.-P., Rajala, K., Pekkanen-Mattila, M., Rasku, J., Larsson, K., & Aalto-Setälä, K. (2016) · Stem Cells International · doi:10.1155/2016/1684792 · Cited by 104
Yang, J., Cai, J., Zhang, Y., Wang, X., Li, W., Xu, J., Li, F., Guo, X., Deng, K., Zhong, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.183392 · Cited by 104
Vaidyanathan, R., Markandeya, Y. S., Kamp, T. J., Makielski, J. C., January, C. T., & Eckhardt, L. L. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00481.2015 · Cited by 104
Modelling Torsade de Pointes arrhythmias in vitro in 3D human iPS cell-engineered heart tissue
Kawatou, M., Masumoto, H., Fukushima, H., Morinaga, G., Sakata, R., Ashihara, T., & Yamashita, J. K. (2017) · Nature Communications · doi:10.1038/s41467-017-01125-y · Cited by 110
Matsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105
Investigating monogenic and complex diseases with pluripotent stem cells
Zhu, H., Lensch, M. W., Cahan, P., & Daley, G. Q. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2951 · Cited by 115
Current status of drug screening and disease modelling in human pluripotent stem cells
Rajamohan, D., Matsa, E., Kalra, S., Crutchley, J., Patel, A., George, V., & Denning, C. (2013) · BioEssays · doi:10.1002/bies.201200053 · Cited by 99
Prondzynski, M., Krämer, E., Laufer, S. D., Shibamiya, A., Pleß, O., Flenner, F., Müller, O. J., Münch, J., Redwood, C. S., Hansen, A., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.05.008 · Cited by 108
Ma, D., Wei, H., Lu, J., Huang, D., Liu, Z., Loh, L. J., Islam, O., Liew, R., Shim, W., & Cook, S. A. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0027-z · Cited by 96
Physiological aspects of cardiac tissue engineering
Eschenhagen, T., Eder, A., Vollert, I., & Hansen, A. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00007.2012 · Cited by 100
Horváth, A., Lemoine, M. D., Löser, A., Mannhardt, I., Flenner, F., Uzun, A. U., Neuber, C., Breckwoldt, K., Hansen, A., Girdauskas, E., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.01.012 · Cited by 101
Lipid metabolism in insect disease vectors
Gondim, K. C., Atella, G. C., Pontes, E. G., & Majerowicz, D. (2018) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2018.08.005 · Cited by 112
Lemoine, M. D., Krause, T., Koivumäki, J. T., Prondzynski, M., Schulze, M. L., Girdauskas, E., Willems, S., Hansen, A., Eschenhagen, T., & Christ, T. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.006035 · Cited by 106
Efficient Generation and Cryopreservation of Cardiomyocytes Derived from Human Embryonic Stem Cells
Xu, C., Police, S., Hassanipour, M., Li, Y., Chen, Y., Priest, C., O‘Sullivan, C., Laflamme, M. A., Zhu, W.-Z., Van Biber, B., et al. (2011) · Regenerative Medicine · doi:10.2217/rme.10.91 · Cited by 101
Ho, J. C., Zhou, T., Lai, W.-H., Huang, Y., Chan, Y.-C., Li, X., Wong, N. L., Li, Y., Au, K.-W., Guo, D., et al. (2011) · Aging · doi:10.18632/aging.100277 · Cited by 93
Towards chamber specific heart-on-a-chip for drug testing applications
Zhao, Y., Rafatian, N., Wang, E. Y., Wu, Q., Lai, B. F. L., Lu, R. X., Savoji, H., & Radisic, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.002 · Cited by 97
Stillitano, F., Hansen, J., Kong, C., Karakikes, I., Funck‐Brentano, C., Geng, L., Scott, S. A., Reynier, S., Ma, W., Valogne, Y., et al. (2017) · eLife · doi:10.7554/elife.19406 · Cited by 99
Creation of mouse embryonic stem cell-derived cardiac cell sheets
Matsuura, K., Masuda, S., Haraguchi, Y., Yasuda, N., Shimizu, T., Hagiwara, N., Zandstra, P. W., & Okano, T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.042 · Cited by 103
Kussauer, S., David, R., & Lemcke, H. (2019) · Cells · doi:10.3390/cells8111331 · Cited by 101
Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing
Sinnecker, D., Laugwitz, K., & Moretti, A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.004 · Cited by 100
Self-citationDefining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells
Álvarez, C. V., García-Lavandeira, M., Garcia-Rendueles, M. E. R., Díaz‐Rodriguez, E., Garcia-Rendueles, Á. R., Pérez-Romero, S., Vila, T. V., Rodrigues, J. S., Lear, P., & Bravo, S. B. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0072 · Cited by 118
Engineering skeletal muscle tissue – new perspectives in vitro and in vivo
Klumpp, D., Horch, R. E., Kneser, U., & Beier, J. P. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01183.x · Cited by 95
hERG 1b is critical for human cardiac repolarization
Jones, D. K., Liu, F., Vaidyanathan, R., Eckhardt, L. L., Trudeau, M. C., & Robertson, G. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414945111 · Cited by 96
Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes
Eschenhagen, T., Mummery, C., & Knollmann, B. C. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv017 · Cited by 97
The electrophysiological development of cardiomyocytes
Liu, J., Laksman, Z., & Backx, P. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.023 · Cited by 106
Jonsson, M. K. B., Wang, Q.-D., & Becker, B. (2011) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2011.0396 · Cited by 94
Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies
Brandão, K. O., Tabel, V. A., Atsma, D. E., Mummery, C. L., & Davis, R. P. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030320 · Cited by 104
Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes
Bizy, A., Guerrero-Serna, G., Hu, B., Ponce-Balbuena, D., Willis, B. C., Zarzoso, M., Ramirez, R. J., Sener, M. F., Mundada, L. V., Klos, M., et al. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.09.003 · Cited by 91
New lessons learned from disease modeling with induced pluripotent stem cells
Önder, T. T., & Daley, G. Q. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.05.005 · Cited by 97
Andrysiak, K., Stępniewski, J., & Dulak, J. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02536-z · Cited by 102
Clinical and Genetic Determinants of Torsade de Pointes Risk
Sauer, A. J., & Newton‐Cheh, C. (2012) · Circulation · doi:10.1161/circulationaha.111.080887 · Cited by 98
Direct Nkx2-5 Transcriptional Repression of Isl1 Controls Cardiomyocyte Subtype Identity
Dorn, T., Goedel, A., Lam, J. T., Haas, J., Tian, X. Y., Herrmann, F. E., Bundschu, K., Dobreva, G. D., Schiemann, M., Dirschinger, R. J., et al. (2014) · Stem Cells · doi:10.1002/stem.1923 · Cited by 101
Self-citationMehta, A. K., Chung, Y. Y., Ng, A., Iskandar, F., Atan, S., Wei, H., Dusting, G. J., Sun, W. Y., Wong, P., & SHIM, W. S. N. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr132 · Cited by 95
Induced pluripotent stem cells and personalized medicine: current progress and future perspectives
Chun, Y. S., Byun, K., & Lee, B. (2011) · Anatomy & Cell Biology · doi:10.5115/acb.2011.44.4.245 · Cited by 105
Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures
Sacchetto, C., Vitiello, L., de Windt, L. J., Rampazzo, A., & Calore, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093404 · Cited by 91
Yamamoto, Y., Makiyama, T., Harita, T., Sasaki, K., Wuriyanghai, Y., Hayano, M., Nishiuchi, S., Kohjitani, H., Hirose, S., Chen, J., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx073 · Cited by 95
Pluripotent Stem Cell Models of Human Heart Disease
Moretti, A., Laugwitz, K.-L., Dorn, T., Sinnecker, D., & Mummery, C. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014027 · Cited by 91
Self-citationPhenotypic Manifestations of Mutations in Genes Encoding Subunits of Cardiac Potassium Channels
Shimizu, W., & Horie, M. (2011) · Circulation Research · doi:10.1161/circresaha.110.224600 · Cited by 103
Metadata
- Authors
- Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., Seyfarth, M., Sinnecker, D., Schömig, A., & Laugwitz, K.-L.
- Affiliations
- TUM Klinikum (DE)
- Deutsches Herzzentrum München (DE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1397-1409
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2104996733
- Cited by
- 1,251
- References
- 40
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 43 · 2023: 49 · 2022: 51 · 2021: 79 · 2020: 56 · 2019: 69 · 2018: 69 · 2017: 89 · 2016: 90 · 2015: 111 · 2014: 90 · 2013: 116 · 2012: 143
- FWCI
- 88.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- LQT1, KCNQ1, induced pluripotent stem cells, patient-specific disease models, cardiomyocyte differentiation, action potential prolongation, delayed rectifier potassium current, beta-adrenergic blockade, sudden cardiac death, ventricular repolarization
- MeSH terms
- Kruppel-Like Factor 4, Action Potentials, Adrenergic beta-Antagonists, Adult, Aged, Cardiotonic Agents, Child, Female, Fibroblasts, Humans, Isoproterenol, Male, Pedigree, Phenotype, Potassium Channels, Gene Expression, Mutation, Missense, Reverse Transcriptase Polymerase Chain Reaction, Potassium Channel Blockers, Romano-Ward Syndrome, Myocytes, Cardiac, KCNQ1 Potassium Channel, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.